Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective
Gastrointestinal Outcomes: Evidence for Risk Reduction in Patients Using Coxibs
The Impact of Nonsteroidal Anti-Inflammatory Drug-Induces Gastropathy